223 related articles for article (PubMed ID: 31031022)
21. Prognostic Relevance of Palliative Primary Tumor Removal in 37,793 Metastatic Colorectal Cancer Patients: A Population-Based, Propensity Score-Adjusted Trend Analysis.
Tarantino I; Warschkow R; Worni M; Cerny T; Ulrich A; Schmied BM; Güller U
Ann Surg; 2015 Jul; 262(1):112-20. PubMed ID: 25373464
[TBL] [Abstract][Full Text] [Related]
22. Long-Term Outcomes of Surgical Management of Pancreatic Neuroendocrine Tumors with Synchronous Liver Metastases.
Partelli S; Inama M; Rinke A; Begum N; Valente R; Fendrich V; Tamburrino D; Keck T; Caplin ME; Bartsch D; Thirlwell C; Fusai G; Falconi M
Neuroendocrinology; 2015; 102(1-2):68-76. PubMed ID: 26043944
[TBL] [Abstract][Full Text] [Related]
23. Resection of primary tumor may prolong survival in metastatic gastroenteropancreatic neuroendocrine tumors.
Tierney JF; Chivukula SV; Wang X; Pappas SG; Schadde E; Hertl M; Poirier J; Keutgen XM
Surgery; 2019 Mar; 165(3):644-651. PubMed ID: 30366604
[TBL] [Abstract][Full Text] [Related]
24. Pancreaticoduodenectomy and metastasectomy for metastatic pancreatic neuroendocrine tumors.
Chawla A; Williams RT; Sich N; Clancy T; Wang J; Ashley S; Pezzi C; Swanson R
J Surg Oncol; 2018 Nov; 118(6):983-990. PubMed ID: 30212595
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Outcomes Following Surgery for Locally Advanced Pancreatic Neuroendocrine Tumors.
Titan AL; Norton JA; Fisher AT; Foster DS; Harris EJ; Worhunsky DJ; Worth PJ; Dua MM; Visser BC; Poultsides GA; Longaker MT; Jensen RT
JAMA Netw Open; 2020 Nov; 3(11):e2024318. PubMed ID: 33146734
[TBL] [Abstract][Full Text] [Related]
26. Malignant-functioning neuroendocrine tumors of the pancreas: A survival analysis.
Keutgen XM; Nilubol N; Kebebew E
Surgery; 2016 May; 159(5):1382-9. PubMed ID: 26704781
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the prognostic value of surgery and postoperative radiotherapy for patients with thymic neuroendocrine tumors: A propensity-matched study based on the SEER database.
Wen J; Chen J; Chen D; Liu D; Xu X; Huang L; Cao J; Zhang J; Gu Y; Fan M; Chen Y
Thorac Cancer; 2018 Dec; 9(12):1603-1613. PubMed ID: 30276969
[TBL] [Abstract][Full Text] [Related]
28. Hepatic Resection for Non-functional Neuroendocrine Liver Metastasis: Does the Presence of Unresected Primary Tumor or Extrahepatic Metastatic Disease Matter?
Xiang JX; Zhang XF; Beal EW; Weiss M; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Pawlik TM
Ann Surg Oncol; 2018 Dec; 25(13):3928-3935. PubMed ID: 30218247
[TBL] [Abstract][Full Text] [Related]
29. Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a multimodal approach.
Bertani E; Fazio N; Botteri E; Chiappa A; Falconi M; Grana C; Bodei L; Papis D; Spada F; Bazolli B; Andreoni B
Surgery; 2014 Apr; 155(4):607-14. PubMed ID: 24582492
[TBL] [Abstract][Full Text] [Related]
30. A prognostic nomogram in patients with distant metastasis of pancreatic neuroendocrine tumors: a population-based study.
Cai JS; Chen HY; Lu YF; Yu RS
Future Oncol; 2020 Jan; 16(2):4369-4379. PubMed ID: 31802701
[No Abstract] [Full Text] [Related]
31. Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.
Gratian L; Pura J; Dinan M; Roman S; Reed S; Sosa JA
Ann Surg Oncol; 2014 Oct; 21(11):3515-21. PubMed ID: 24841347
[TBL] [Abstract][Full Text] [Related]
32. Aggressive surgical resection in the management of pancreatic neuroendocrine tumors: when is it indicated?
Hodul PJ; Strosberg JR; Kvols LK
Cancer Control; 2008 Oct; 15(4):314-21. PubMed ID: 18813199
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of resected nonfunctional pancreatic neuroendocrine tumors: Do size and symptoms matter?
Sallinen V; Haglund C; Seppänen H
Surgery; 2015 Dec; 158(6):1556-63. PubMed ID: 26070847
[TBL] [Abstract][Full Text] [Related]
34. Laparoscopic versus open distal pancreatectomy for nonfunctioning pancreatic neuroendocrine tumors: a large single-center study.
Han SH; Han IW; Heo JS; Choi SH; Choi DW; Han S; You YH
Surg Endosc; 2018 Jan; 32(1):443-449. PubMed ID: 28664429
[TBL] [Abstract][Full Text] [Related]
35. Life expectancy in pancreatic neuroendocrine cancer.
Brooks JC; Shavelle RM; Vavra-Musser KN
Clin Res Hepatol Gastroenterol; 2019 Feb; 43(1):88-97. PubMed ID: 30220478
[TBL] [Abstract][Full Text] [Related]
36. Predicting Aggressive Behavior in Nonfunctional Pancreatic Neuroendocrine Tumors With Emphasis on Tumor Size Significance and Survival Trends: A Population-Based Analysis of 1787 Patients.
Fathi AH; Romanyshyn J; Barati M; Choudhury U; Chen A; Sosa JA
Am Surg; 2020 May; 86(5):458-466. PubMed ID: 32684030
[TBL] [Abstract][Full Text] [Related]
37. Prognostic factors in 151 patients with surgically resected non-functioning pancreatic neuroendocrine tumours.
Song KB; Kim SC; Kim JH; Hong SM; Park KM; Hwang DW; Lee JH; Lee YJ
ANZ J Surg; 2016 Jul; 86(7-8):563-7. PubMed ID: 25040037
[TBL] [Abstract][Full Text] [Related]
38. Palliative resection of primary site in advanced gastroenteropancreatic neuroendocrine tumors improves survivals.
Kıvrak Salim D; Bayram S; Gömceli İ; Çekin AH; Karaca M; Koçer M; Yıldız M
Turk J Gastroenterol; 2019 Oct; 30(10):910-916. PubMed ID: 31625933
[TBL] [Abstract][Full Text] [Related]
39. Surgical resection of high-grade nonfunctional pancreatic neuroendocrine carcinoma is associated with improved survival.
Jiang J; Park J; Kim S; Daan A; Donahue T; Girgis MD
J Surg Oncol; 2021 Dec; 124(8):1373-1380. PubMed ID: 34406651
[TBL] [Abstract][Full Text] [Related]
40. Sporadic nonfunctioning pancreatic neuroendocrine tumors: prognostic significance of incidental diagnosis.
Birnbaum DJ; Gaujoux S; Cherif R; Dokmak S; Fuks D; Couvelard A; Vullierme MP; Ronot M; Ruszniewski P; Belghiti J; Sauvanet A
Surgery; 2014 Jan; 155(1):13-21. PubMed ID: 24238123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
